SafeRx Pharmaceuticals Inc. — Form C-U (Regulation Crowdfunding)
SafeRx Pharmaceuticals Inc. of LENOX, MA filed a Form C-U (Regulation Crowdfunding) with the SEC on 2022-05-02. Target raise $25K, up to $5.0M. Offered through DALMORE GROUP LLC.
Offering
- Filed: 2022-05-02
- Form: C-U
- Accession: 0001644600-22-000063
- Target amount: $25K
- Maximum amount: $5.0M
- Security type: Common Stock
- Securities offered: 2,262,443
- Price: $2.2100
- Deadline: 2022-04-30
- Funding portal / intermediary: DALMORE GROUP LLC
- Intermediary file number: 008-67002
- Intermediary CRD: 000136352
Issuer
- CIK: 0001850523
- Website: https://saferxpharmaceuticals.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2021-05-10
- Address: PO BOX #2102, LENOX, MA, 01240
- Employees: 2
Financials (as filed)
- Total assets (most recent): $175K
- Cash (most recent): $175K
- Net income (most recent): $-822K
- Short-term debt: $818K
People (1)
| Name | Role | Location |
|---|
| Michael Presti | President, Chief Executive Officer, and Secretary | LENOX, MA |
Reg CF filing history (4)
More